Healio Pulmonology has compiled the top news on cystic fibrosis posted in 2022.
Our most-read stories of the year include data on an inhalation therapy, the FDA’s approval of lumacaftor and ivacaftor (Orkambi, Vertex Pharmaceuticals) for children, vitamin C impacting alpha-tocopherol concentrations, a higher BMI leading to favorable outcomes and the benefits and limitations of newborn screening.
Here are Healio’s top 10 most-read stories on cystic fibrosis from 2022.
Combining manuka honey and the antibiotic amikacin in a lab-based nebulization formulation was effective for